Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
Yan Mei, Xiumei Wang, Ji Zhang, Dan Liu, Junjie He, Chunliu Huang, Jing Liao, Yingzhao Wang, Yong-Yi Feng, Hongyu Li, Xiuying Liu, Lingdan Chen, Yi Wei, Xi Chen, Hongmin Bai, Xinyu Wang, Yiyi Li, Lixiang Wang, Zhigang Liang, Xianwen Ren, Qiu Li, Hui Yuan, Qingling Zhang, Qibin Leng, Jun Chen, Guangshuai Jia
Topics & Concepts
Cancer researchImmunotherapyImmune checkpointImmune systemCD8T cellBlockadeChemokineCytotoxic T cellPriming (agriculture)BiologyDendritic cellMyeloidImmunologyReceptorGerminationIn vitroBotanyBiochemistryImmune cells in cancerSingle-cell and spatial transcriptomicsGlioma Diagnosis and Treatment